Come up with a name for your new list and we'll add to it:
Brainsgate raised a round of funding on August 11, 2005. Investors include
Elron Electronic Industries.
BrainsGate develops a technology for modulation of cerebro-vascular properties through neuro-stimulation of the spheno-palatine ganglion. Affected properties are central to many CNS disorders - blood …